Metolazone and Breathing difficulty - a phase IV clinical study of FDA data
Summary:
Breathing difficulty is found among people who take Metolazone, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Metolazone and have Breathing difficulty. It is created by eHealthMe based on reports of 12,195 people who have side effects when taking Metolazone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
12,195 people reported to have side effects when taking Metolazone.
Among them, 1,458 people (11.96%) have Breathing difficulty.
What is Metolazone?
Metolazone has active ingredients of metolazone. It is often used in swelling. eHealthMe is studying from 12,267 Metolazone users for its effectiveness, alternative drugs and more.
What is Breathing difficulty?
Breathing difficulty is found to be associated with 4,864 drugs and 5,838 conditions by eHealthMe.
Number of Metolazone and Breathing difficulty reports submitted per year:
Time on Metolazone when people have Breathing difficulty *:
Gender of people who have Breathing difficulty when taking Metolazone*:
Age of people who have Breathing difficulty when taking Metolazone *:
Common drugs people take besides Metolazone *:
Common side effects people have besides Breathing difficulty *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Metolazone and have Breathing difficulty?
Check whether Breathing difficulty is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Breathing difficulty and when was it recovered:
Expand to all the drugs that have ingredients of metolazone:
- Breathing difficulty and drugs with ingredients of metolazone (1,792 reports)
Alternative drugs to, pros and cons of Metolazone:
- Metolazone (12,267 reports)
Common Metolazone side effects:
- Breathing difficulty: 1,469 reports
- Acute kidney failure: 981 reports
- Hypotension (abnormally low blood pressure): 876 reports
- Fatigue (feeling of tiredness): 875 reports
- Weakness: 866 reports
Browse all side effects of Metolazone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBreathing difficulty treatments and more:
- Breathing difficulty (579,752 reports)
COVID vaccines that are related to Breathing difficulty:
- Breathing difficulty in Moderna COVID Vaccine
- Breathing difficulty in Pfizer BioNTech Covid Vaccine
- Breathing difficulty in Johnson and Johnson Covid Vaccine
Common drugs associated with Breathing difficulty:
- Prednisone: 37,839 reports
- Aspirin: 30,142 reports
- Spiriva: 25,479 reports
- Symbicort: 20,576 reports
- Furosemide: 19,428 reports
- Albuterol: 17,779 reports
- Omeprazole: 17,638 reports
- Methotrexate: 17,095 reports
- Lasix: 16,702 reports
- Metformin: 16,584 reports
All the drugs that are associated with Breathing difficulty:
- Breathing difficulty (4,864 drugs)
Common conditions associated with Breathing difficulty:
- Asthma: 40,041 reports
- Primary pulmonary hypertension: 34,524 reports
- High blood pressure: 26,686 reports
- Rheumatoid arthritis: 25,046 reports
- Chronic obstructive pulmonary disease: 24,688 reports
- Pain: 15,332 reports
All the conditions that are associated with Breathing difficulty:
- Breathing difficulty (5,838 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on metolazone (the active ingredients of Metolazone) and Metolazone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Claritin-D 24 Hour and Dry Eyes - 5 seconds ago
- Famvir and Face Oedema - 5 seconds ago
- Chloroquine Phosphate and Stomach Discomfort - 7 seconds ago
- Melphalan and Raltegravir drug interaction - 7 seconds ago
- Tamiflu and Gastrointestinal Haemorrhage - 13 seconds ago
- Lutein and Elocon drug interaction - 21 seconds ago
- Vascepa and Meclizine Hydrochloride drug interaction - 23 seconds ago
- Gallstones and Blood Urea Increased - 23 seconds ago
- Nateglinide and Gastric Cancer - 34 seconds ago
- Magnesium Oxide and Xarelto drug interaction - 42 seconds ago